Varlilumab: A Deep Dive into CDX-1127 and its Mechanism The antibody (formerly known as compound CDX-1127) represents a novel immunotherapeutic approach targeting this surface receptor. Its mode of action involves https://www.targetmol.com/compound/varlilumab